Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Global Cord Blood Corporation stock

Own Global Cord Blood Corporation stock in just a few minutes.

Global Cord Blood Corporation is a diagnostics & research business based in the US. Global Cord Blood Corporation shares (CO) are listed on the NYSE and all prices are listed in US Dollars. Global Cord Blood Corporation employs 1,260 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Global Cord Blood Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Global Cord Blood Corporation share price

Use our graph to track the performance of CO stocks over time.

Global Cord Blood Corporation shares at a glance

Information last updated 2021-04-30.
52-week range$2.54 - $4.98
50-day moving average $4.67
200-day moving average $4.20
Wall St. target price$15.00
PE ratio 8.0033
Dividend yield $0.076 (1.59%)
Earnings per share (TTM) $0.61

Buy Global Cord Blood Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Global Cord Blood Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Global Cord Blood Corporation under- or over-valued?

Valuing Global Cord Blood Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Cord Blood Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Global Cord Blood Corporation's P/E ratio

Global Cord Blood Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Global Cord Blood Corporation shares trade at around 8x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Global Cord Blood Corporation's EBITDA

Global Cord Blood Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $593.2 million.

The EBITDA is a measure of a Global Cord Blood Corporation's overall financial performance and is widely used to measure a its profitability.

Global Cord Blood Corporation financials

Revenue TTM $1.2 billion
Operating margin TTM 47.18%
Gross profit TTM $1 billion
Return on assets TTM 4.6%
Return on equity TTM 12.05%
Profit margin 41.27%
Book value $35.00
Market capitalisation $589.5 million

TTM: trailing 12 months

Shorting Global Cord Blood Corporation shares

There are currently 769,731 Global Cord Blood Corporation shares held short by investors – that's known as Global Cord Blood Corporation's "short interest". This figure is 92.4% up from 400,001 last month.

There are a few different ways that this level of interest in shorting Global Cord Blood Corporation shares can be evaluated.

Global Cord Blood Corporation's "short interest ratio" (SIR)

Global Cord Blood Corporation's "short interest ratio" (SIR) is the quantity of Global Cord Blood Corporation shares currently shorted divided by the average quantity of Global Cord Blood Corporation shares traded daily (recently around 157087.95918367). Global Cord Blood Corporation's SIR currently stands at 4.9. In other words for every 100,000 Global Cord Blood Corporation shares traded daily on the market, roughly 4900 shares are currently held short.

However Global Cord Blood Corporation's short interest can also be evaluated against the total number of Global Cord Blood Corporation shares, or, against the total number of tradable Global Cord Blood Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Global Cord Blood Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Global Cord Blood Corporation shares in existence, roughly 10 shares are currently held short) or 0.0222% of the tradable shares (for every 100,000 tradable Global Cord Blood Corporation shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Global Cord Blood Corporation.

Find out more about how you can short Global Cord Blood Corporation stock.

Global Cord Blood Corporation share dividends

We're not expecting Global Cord Blood Corporation to pay a dividend over the next 12 months.

Global Cord Blood Corporation share price volatility

Over the last 12 months, Global Cord Blood Corporation's shares have ranged in value from as little as $2.54 up to $4.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Global Cord Blood Corporation's is 0.3883. This would suggest that Global Cord Blood Corporation's shares are less volatile than average (for this exchange).

Global Cord Blood Corporation overview

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. .

Frequently asked questions

What percentage of Global Cord Blood Corporation is owned by insiders or institutions?
Currently 71.426% of Global Cord Blood Corporation shares are held by insiders and 16.937% by institutions.
How many people work for Global Cord Blood Corporation?
Latest data suggests 1,260 work at Global Cord Blood Corporation.
When does the fiscal year end for Global Cord Blood Corporation?
Global Cord Blood Corporation's fiscal year ends in March.
Where is Global Cord Blood Corporation based?
Global Cord Blood Corporation's address is: Bank of China Tower, Central, Hong Kong
What is Global Cord Blood Corporation's ISIN number?
Global Cord Blood Corporation's international securities identification number is: KYG393421030
What is Global Cord Blood Corporation's CUSIP number?
Global Cord Blood Corporation's Committee on Uniform Securities Identification Procedures number is: 698659109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site